Biotechnology Industry Organization (BIO) Joins AdvaMed, PhRMA In Letter Expressing Concerns With Sunshine Act Implementation

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WASHINGTON--(BUSINESS WIRE)--BIO President and CEO James Greenwood joined AdvaMed President and CEO Stephen Ubl and PhRMA President and CEO John Castellani in a letter to CMS Administrator Marilyn Tavenner highlighting ongoing concerns about a potential lack of necessary context around the Sunshine data release.

BIO is a member of Partners for Healthy Dialogues, a coalition which has brought industry together with doctors to educate policy makers, patients, providers and other stakeholders about the essential role these relationships play in lifesaving medical breakthroughs, the safe and effective use of medical technologies, the development of new medicines and technologies, and improvements in the care we all receive.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC